The BioWorld Insider Podcast
Iteos brings Glaxosmithkline a third checkpoint-targeting antibody in a $2B deal
Jun 16, 2021
12:33
S1 · E2
-(0)
About this episode
Michel Detheux, president and CEO of Iteos Therapeutics Inc., discusses what his company brings GSK in a massive new deal. Hosted on Acast. See acast.com/privacy for more information.
Comments
Rate this episode
Episode Details
- Show Type
- full
- Audio Format
- audio/mpeg